Literature DB >> 16580948

Coronary artery disease and nuclear imaging in renal failure.

Tochi Okwuosa1, Kim A Williams.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16580948     DOI： 10.1007/bf02971236

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  33 in total

1.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

Review 2.  Homocysteine and cardiovascular disease.

Authors:  Dinesh K Kalra
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

3.  Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease.

Authors:  Mili Gupta; Priyanka Sharma; Gitanjali Garg; Kiranjeet Kaur; Gurdeep Kaur Bedi; Anil Vij
Journal:  Clin Chim Acta       Date:  2005-02       Impact factor: 3.786

Review 4.  Coronary artery disease in uremia: Etiology, diagnosis, and therapy.

Authors:  D J Goldsmith; A Covic
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

Review 5.  Ethiopathogenesis, diagnosis and prevention of vascular calcification in end stage renal disease.

Authors:  Emiliana Ferramosca; Antonio Bellasi; Carlo Ratti; Paolo Raggi
Journal:  Curr Med Chem Cardiovasc Hematol Agents       Date:  2005-04

Review 6.  Homocysteinemia and vascular disease in end-stage renal disease.

Authors:  V W Dennis; K Robinson
Journal:  Kidney Int Suppl       Date:  1996-12       Impact factor: 10.545

7.  Myocyte/capillary mismatch in the heart of uremic patients.

Authors:  K Amann; M Breitbach; E Ritz; G Mall
Journal:  J Am Soc Nephrol       Date:  1998-06       Impact factor: 10.121

8.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

9.  Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.

Authors:  Gherardo Buccianti; Ivano Baragetti; Fabrizia Bamonti; Silvia Furiani; Valentina Dorighet; Cristina Patrosso
Journal:  J Nephrol       Date:  2004 May-Jun       Impact factor: 3.902

10.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.

Authors:  J Braun; M Oldendorf; W Moshage; R Heidler; E Zeitler; F C Luft
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860
View more
  5 in total

1.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

2.  Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?

Authors:  Erica O Miller; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-12-01       Impact factor: 5.952

3.  American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI).

Authors:  R Parker Ward; Mouaz H Al-Mallah; Gabriel B Grossman; Christopher L Hansen; Robert C Hendel; Todd C Kerwin; Benjamin D McCallister; Rupa Mehta; Donna M Polk; Peter L Tilkemeier; Aseem Vashist; Kim Allan Williams; David G Wolinsky; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

4.  Chronic kidney disease, SPECT, and coronary angiography: "head of gold and feet of clay?".

Authors:  Kim A Williams
Journal:  J Nucl Cardiol       Date:  2009-04-28       Impact factor: 5.952

5.  Clinical utility of estimated glomerular filtration rate in patients undergoing gated SPECT.

Authors:  Michele Coceani; Alessia Gimelli; Clara Carpeggiani; Antonio L'abbate; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.